Dr A C Alliso (Clinical Research Centre Laboratories, National Institutefor Medical Research, London) pm mto Virus-induc!ed Tumours Much experimental work has established that tumours induced by viruses in inbred strains of animals have specific antigens. Thus, immunization of an animal with a particular virus will produce resistance against all tumours induced by that virus, but not against tumours induced by other viruses (Hellstrom & Moller 1965) .
This paper is concerned with the immune responses of the host and the role these play in limiting tumour formation under various conditions. During the past few years we have concentrated on the effects of immunosuppression. If this increases tumour formation significantly, it is reasonable to conclude that an immune response is limiting tumour formation under the conditions of the experiment. The magnitude of the difference in oncogenesis in normal and immunosuppressed animals provides some measure of the effeciveness of the une response.
The most striking examples of immunity are provided by the effects of rapidly oncogenic viruses in adult animals, e.g. the Shope fibroma and papilloma viruses in rabbits, the Yaba virus in monkeys and the Rous sarcoma virus in fowls. Within a few days of virus inoculation, a tumour mass appears which grows rapidly for some time but later disappears. Animals which have recovered from the primary tumour do not develop tumours after second injections of the virus. We found that the resistance of rabbits to superinfection with fibroma virus appeared five days after the primary virus inoculation, at the time when delayed hypersensitivity to the virus develops (Allison & Fiiedman 1966) . In rabbits treated with the immunosuppressants methotrexate or cortisone, two differences from normal were noticed: the primary tumours grew to a much larger size than in controls and regression was markedly delayed; and many tumours appeared, distant from the original inoculation sites. Injections of serum containing antibody into the methotrexate-treated rabbits prevented the appearance of tumours at distant sites, but did not accelerate the regression of the primary tumours. From this and other evidence we concluded that antibody prevents the spread of virus, but that the immune response brnging about the regression of the primary tumour is cell-mediated. In newbom rabbits, the fibroma grows to an enormous size and kills the animals, antibody is formed but cell-mediated immunity cannfot be demonstrated (Allison 1966) .
It is well recognized that newborn animals, especially hamsters, mice and rats, are susceptible to virus oncogenesis. With many viruses, e.g. earlypassage Gross leukamogenic virus, polyoma virus, SV40 and oncogenic adenovirus, tumours are readily induced after injections into newborn animals, but are usually not seen after injections into adults. The latter statement requires some qualification, as will appear below, but there is no doubt as to the much greater susceptibility of the newborns. The first question is whether this difference reflects the ease of transformation by the virus corresponding, for example, to the state of differentiation of the tissues, or whether it is due to differences in immune responses in newborn and adult animals. Two lines of evidence make it clear that the latter is the case. Organ cultures of salivary gland and kidney from adult animals are just as easily transformed by polyoma virus as are cultures from newborn animals, and many tumours appear in adult animals treated with immunosuppressives.
What is the nature of the difference in immune response between newborn and adult animals? The first view, advocated by Habel (1962) , was that 'the newborn, being immunologically incompetent, tolerates the new antigen and allows tumour growth, whereas the immunologically mature adult rejects the antigen and-thus becomes hypersensitive or immune to later challenge with tumor'. With avian and murine leuktmogenic viruses there are reports that tolerance can be induced by exposure before or shortly after hatching or birth (Rubin et al. 1961 , Axelrad 1965 , Klein & Klein 1965 , Chieco-Bianchi et al. 1967 ) and suggestions that this may be true also of the mammary tumour agent (Morton 1964 , Attia et al. 1965 .
However, tolerance is unlikely to provide a general explanation for the susceptibility of newborn animals to virus oncogenesis (Allison 1964) . In all the systems so far studied, injection of virus into the newborn elicits the formation of antibody which neutralizes the virus, inhibits hxmagglutination or gives a reaction with Tantigen demonstrable by immunofluorescence.
It is, of course, possible that none of the antigens shown by these reactions is related to the tumour-specific antigens giving rise to resistance against transplantation, and that antibody does not in any case contribute significantly to tumour cell rejection. However, there is much evidence that animals exposed to viruses as newborns are sensitized against the tumour cells and are not tolerant. The first point is that after some delay they resist transplantation of syngeneic tumour cells carrying the same antigen . (Vandeputte & De Somer 1963) . Secondly, in the case of both SV40 and adenovirus type 12, further injections Many of the tumours observed after ALS treatment were reticulum-cell sarcomas. It was concluded that the thymic elements required for neoplastic conversion by MLV are not eliminated by ALS, which may alter the pathology of the induced tumours by a combination of immunosuppression and capacity to stimulate the proliferation of primitive lymphoid cells. Potentiation of leukemogenesis by the Rauscher virus by ALS has also been observed by Hirsch & Murphy (1968) .
Because of the observations summarized above I was led to postulate that there are two classes of oncogenic viruses, some that are toleranceinducing when introduced into the newborn animal and some that are not, as summarized in Table 1 (Allison 1967) . Some at least of the tolerance-inducing viruses can multiply in lymphocytes, whereas the viruses in the second group apparently cannot, and the presence of a relatively high concentration of antigen in lymphocytes seemed a reasonably plausible explanation for the failure of immune responses in these animalsanalogous to the high-dose tolerance produced with several antigens (Dresser & Mitchison 1968 ). This might also allow the 'vertical transmission' of these viruses from mothers to offspring by way of the placenta (lymphocytic choriomeningitis (LCM) and Gross leukiemogenic virus) or milk (mammary tumour agent or Moloney leukemogenic virus).
However, recent results cast doubt on one feature of this scheme, and suggest that antibodies can in fact be formed after neonatal infection with at least some of the supposedly tolerance-inducing viruses, and are demonstrable in the renal glomeruli where they are presumably deposited in the form of antigen-antibody complexes. This has been shown for LCM by Oldstone & Dixon (1967) and for Moloney leukwmogenic and murine sarcoma viruses by Hirsch et al. (1969) . The antibody can be eluted from the glomeruli and shown to fix complement or neutralize the homologous virus. Virus in the circulation appears to be in the form of nonneutralized complexes with antibody, titres of of which are markedly reduced by treatment with anti-mouse-immunoglobulin sera. Possibly there is split tolerance, with some antibody production but no cell-mediated immunity. Possibly the tests for cell-mediated immunity have been too insensitive to demonstrate its presence in these animals.
We are experimenting with what promises to be a more sensitive test, which should help to decide the point. The main difference between cellmediated immune responses in animals exposed to viruses of the second group as newborns and adults seems to be the delay in development of immunity in the newborn. We have found that lymph node or spleen cells taken from an adult ten days after polyoma virus infection are fully sensitized, as judged by their capacity to prevent the appearance of tumours when transferred to a sensitive syngeneic system. In contrast, spleen cells taken from a mouse ten days after infection with polyoma virus as a newborn show no demonstrable sensitization, while at six weeks they are fully sensitized. In this system antibody passively transferred after infection has no demonstrable effect in either limiting or enhancing tumour growth.
Adult animals are not completely resistant to oncogenesis by these viruses. Thus, some adult hamsters inoculated with polyoma virus and SV40 develop tumours, usually after a long latent period (Barski et al. 1962 , Allison et al. 1967 . Adult mice are highly resistant to polyoma virus oncogenesis, but if the mice have been thymectomized in the neonatal period adult infections often result in tumour development (Law 1966 , Allison & Taylor 1967 .
The most striking potentiation was observed in some experiments recently carried out unintentionally by my colleagues Gaugas et al. (1969) . They were attempting to propagate -human leprosy in CBA mice made immunologilly deficient by adult thymectomy and repeated ALS injections. All the mice were infected in the laboratory with polyoma virus, and every one of 48 thymectomized mice receiving ALS developed multiple polyoma tumours whereas not one of 48 controls thymectomized but not given ALS or of 24 intact controls developed a tumour. The combination of thymectomy and ALS is the most potent immunosuppressive procedure at present known, and its effect on polyoma virs oncogenesis in adult animals is certainly stiking. It also demonstrates the effetiveness of imm ity in limiting tumour development in the adult mouse.
Does this type of immunological surveillance mechanism operate also in man? Two sets of observations suggest that it may. The first is that children with congenital imune deficiency syndromes, especially those involving cell-mediated immunity, show an increased tendency to develop malignancycommonly but not always of the lymphoreticular system (Good 1969) . Moreover, T Starzl (personal communication) and several others have observed reticulum-cell sarcomas and other tumours in patients on immunosuppressive therapy after renal homografting. At a recent meeting on tumour immunity sponsored by the American Cancer Society the existen offourteen patients with such tumours was reported, which is many times that expected in a comparable age group of healthy subjects. Although further analyses are obviously required, the results suggest that children with immune deficiency syndromes or adults treated with immunosuppressives have a greatly increased risk of developing tumours, especially of the lymphoreticular system. Presumably this represents breakdown of the immunological surveillance mechanism, allowing proliferation of tumour cells that would otherwise be restrained by an immune response. Whether one or more viruses are involved cannot be stated on existing evidence.
